Internal Reference Number: FOI_9041
Date Request Received: 17/11/2025 00:00:00
Date Request Replied To: 29/12/2025 00:00:00
This response was sent via: By Email
Request Summary: COPD
Request Category: Researcher
| Question Number 1: Within your Trust, how many patients in total were admitted as inpatients between July 鈥� October 2025 with a primary cause of admission being a chronic obstructive pulmonary disease (COPD) exacerbation (ICD-10: J44.1)? | |
| Answer To Question 1: Please see answers to all questions of this FOI in the spreadsheet attached. To accompany this answer to question 1 please also see the documents listed below:  13358 - FOI_9041 - COPD FOR ISSUE.xlsx | |
| Question Number 2: Of the patients admitted with a primary COPD exacerbation (ICD-10: J44.1) identified in Q1, how many were already prescribed a closed triple therapy* at the point of admission? *Closed triple therapy = Trelegy, Trixeo, or Trimbow (any formulation) *鈥淎lready prescribed鈥� means the therapy was documented as active on admission, either from hospital records or patient-reported history. | |
| Answer To Question 2: Please see answers to all questions of this FOI in the spreadsheet attached. | |
| Question Number 3: How many patients in total were prescribed Trixeo for COPD (ICD-10: J44.1) between July 鈥� October 2025? How many of these were new to Trixeo*? *New to Trixeo = Patient not prescribed Trixeo in your hospital (inpatient or outpatient) in the past 12 months (Nov 2024 鈥� Oct 2025), and not currently prescribed Trixeo鈥攚hether prescribed in hospital or community settings鈥攁t the point of admission. | |
| Answer To Question 3: Please see answers to all questions of this FOI in the spreadsheet attached. | |
| Question Number 4: How many patients in total were prescribed Trimbow MDI (for COPD [ICD-10: J44.1]) between July 鈥� October 2025? 鈥� How many of these were new to Trimbow MDI*? 鈥� Of the new Trimbow MDI patients*, what was the split between: 鈥� Trimbow MDI 87/5/9 鈥� Trimbow MDI 172/5/9 *New to Trimbow MDI = Patient not prescribed Trimbow MDI in your hospital (inpatient or outpatient) in the past 12 months (Nov 2024 鈥� Oct 2025), and not currently prescribed Trimbow MDI鈥攚hether prescribed in hospital or community settings鈥攁t the point of admission. | |
| Answer To Question 4: Please see answers to all questions of this FOI in the spreadsheet attached. | |
| Question Number 5: How many patients in total were prescribed Trelegy for COPD (ICD-10: J44.1) between July 鈥� October 2025? How many of these were new to Trelegy*? *New to Trelegy = Patient not prescribed Trelegy in your hospital (inpatient or outpatient) in the past 12 months (Nov 2024 鈥� Oct 2025), and not currently prescribed Trelegy鈥攚hether prescribed in hospital or community settings鈥攁t the point of admission. | |
| Answer To Question 5: Please see answers to all questions of this FOI in the spreadsheet attached. | |
| Question Number 6: How many patients in total were prescribed Trimbow DPI (for COPD [ICD-10: J44.1]) between July 鈥� October 2025? How many of these were new to Trimbow DPI*? *New to Trimbow DPI = Patient not prescribed Trimbow DPI in your hospital (inpatient or outpatient) in the past 12 months (Nov 2024 鈥� Oct 2025), and not currently prescribed Trimbow DPI鈥攚hether prescribed in hospital or community settings鈥攁t the point of admission. | |
| Answer To Question 6: Please see answers to all questions of this FOI in the spreadsheet attached. | |
| Please see Attachments: | |
| To return to the list of all the FOI requests please click here | |
Our staff at 91影视 District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.
